Stereotactic Body Radiation Therapy for Oligometastatic Disease: A Multi-Institutional Retrospective Survival Analysis
D. Bui(Yale University), Roy H. Decker(Yale University), Timothy D. Shafman(Brigham and Women's Hospital), N.H. Lester-Coll(University of Vermont), Jack M. Qian(South Shore Hospital), William J. Magnuson(University of the Aegean), James B. Yu(Harvard University), Arie P. Dosoretz(Yale University), Cary P. Gross(Yale Cancer Center), Pamela R. Soulos(Yale University), R. Ross(21st Century Oncology (United States)), Suzanne B. Evans(Yale University)
International Journal of Radiation Oncology*Biology*Physics
September 23, 2017
Cited by 0
Related Papers
Defining oligometastatic disease from a radiation oncology perspective: An ESTRO-ASTRO consensus document
|Radiotherapy and Oncology|2020|646
Early Assessment of Lung Cancer Immunotherapy Response via Circulating Tumor DNA
|Clinical Cancer Research|2018|456
Large language models to identify social determinants of health in electronic health records
|npj Digital Medicine|2024|275
Artificial intelligence in radiation oncology: A specialty-wide disruptive transformation?
|Radiotherapy and Oncology|2018|252